Cargando…
The cost-effectiveness of treatment in chronic HBV non-cirrhotic hepatitis – finite versus long-life therapy
Autores principales: | Popescu, Cristina, Popescu, Gabriel Adrian, Lobodan, Alina, Rădulescu, Mihaela, Negru, Anca-Ruxandra, Petre, Roxana, Molagic, Violeta, Covaliov, Cristina, Manea, Adriana, Aramă, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239559/ http://dx.doi.org/10.1186/1471-2334-14-S7-P16 |
Ejemplares similares
-
Predictive factors of response to interferon in chronic HBV hepatitis
por: Popescu, Cristina, et al.
Publicado: (2014) -
Spondylodiscitis in Romania – between the risks of prolonged antimicrobial therapy and the poor access to neurosurgery
por: Lobodan, Alina, et al.
Publicado: (2014) -
Treatment of chronic HBV hepatitis – between immune control and virological control
por: Popescu, Cristina, et al.
Publicado: (2014) -
The multiple faces of tuberculosis in HIV infected patients – a continuous challenge
por: Dulamă, Raluca Ioana, et al.
Publicado: (2014) -
HBV reactivation under immunosuppressive treatment – a case series
por: Rădulescu, Mihaela, et al.
Publicado: (2014)